Related Experiment Video
Updated: May 30, 2025

07:15
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
6.7K
Novel machine learning algorithm in risk prediction model for pan-cancer risk: application in a large prospective
Xifeng Wu1,2,3,4,5, Huakang Tu1,2, Qingfeng Hu1
1Department of Big Data in Health Science School of Public Health, and Center of Clinical Big Data and Analytics of The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
BMJ Oncology
|January 31, 2025
Summary
Machine learning models predict pan-cancer risk using routine health data in Asians. XGBoost models show good accuracy, identifying high-risk individuals with significantly increased cancer incidence.
Area of Science:
- Oncology
- Bioinformatics
- Public Health
Background:
- Pan-cancer incidence prediction is crucial for early detection and prevention strategies.
- Leveraging routine health check-up data offers a scalable approach for risk assessment in large populations.
Purpose of the Study:
- To develop and validate machine-learning models for predicting pan-cancer incidence risk.
- To utilize demographic, questionnaire, and routine health check-up data in a large Asian cohort.
Main Methods:
- A prospective cohort study of 433,549 participants (male and female cohorts) over an 8-year median follow-up.
- Development and comparison of machine learning models including XGBoost, Lasso-Cox, and Random Survival Forests.
- Evaluation of model performance using Area Under the Curve (AUC) and identification of key predictive variables.
Main Results:
- XGBoost demonstrated superior performance in predicting pan-cancer incidence compared to other models.
- Optimized models with fewer variables (31 for males, 11 for females) maintained high predictive accuracy (AUCs ranging from 0.746 to 0.876).
- High-risk individuals identified by the models exhibited at least a ninefold higher risk of pan-cancer incidence.
Conclusions:
- The study successfully developed and internally validated machine-learning models for pan-cancer risk prediction using routine health data.
- These models demonstrate good discriminatory ability with a parsimonious set of predictors.
- External validation is recommended prior to clinical implementation of the risk prediction model.

